Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy.
Seyed Mohammad MiriElham TafsiriWilliam Chi Shing ChoAmir GhaemiPublished in: Cancer cell international (2020)
[This corrects the article DOI: 10.1186/s12935-020-01546-8.].
Keyphrases